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Cardiac disease in young adult patients with end-stage renal its late sequelae. Improvement in dialysis technique and
disease since childhood: A Dutch cohort study. supportive therapy over the last two decades, such as
Background. Cardiovascular disease is the most important the introduction of bicarbonate buffer or peritoneal dial-cause of death in patients with pediatric end-stage renal disease
ysis and the use of recombinant erythropoietin (EPO),(ESRD). Yet, few data exist on cardiac function in these pa-
have been associated with a decrease in morbidity andtients. We assessed the extent of cardiac abnormality and ana-
lyzed its association with potential determinants in young adult mortality [1–3]. Nevertheless, detailed information of
patients with pediatric ESRD in a long-term follow-up study. long-term outcomes of renal replacement therapy (RRT)
Methods. All Dutch living adult patients with ESRD onset
in children is lacking.at age of 0 to 14 years between 1972 and 1992 were invited
In adults, cardiovascular disease has been recognizedfor echocardiography and blood pressure assessment. Special
attention was paid to evidence of left ventricular hypertrophy as the most important cause of death in patients with ESRD
(LVH), diastolic dysfunction, and aortic valve calcification. We [4–8]. Left ventricular hypertrophy (LVH) is the most
collected data on determinants by review of all medical charts. frequently observed alteration in these patients and hasResults. Of all the 187 living patients, 140 participated in
been directly associated with acute death [5, 7]. Chronicthe study. Of those, 110 patients had received a transplant and
30 patients were on dialysis. Mean age was 29.2 (20.7 to 41.8) pressure and volume overload, as a result of water and
years. Left ventricular mass index (LVMI) exceeded 150 g/m2 salt retention and hypertension, and the use of cyclospo-
in 47% of all male patients and 120 g/m2 in 39% of all female rine in transplantation have been regarded as potentialpatients, both consistent with LVH. Diastolic dysfunction, de-
risk factors in the development of LVH in older adultfined as an early over atrial transmitral blood flow velocity
patients with ESRD [6, 9]. Enhanced calcification of the(E/A ratio) 1, was found in 18 (13%) patients; 27 (19%) had
aortic valve calcification. Multiple regression analysis revealed aortic valve as a result of chronic volume overload and
the following: a high LVMI was associated with a current high a high serum calcium-phosphate product has recently
blood pressure (  0.46, P  0.001) and male gender ( 
been recognized as another independent risk factor for0.21, P  0.009), a low E/A ratio with aging (  0.28, P 
acute death in adult patients with ESRD [10, 11].0.001) and a glomerular filtration rate (GFR) 25 mL/min/
1.73 m2 (  0.29, P  0.001), and aortic valve calcification To date, few data exist on cardiac disease in young
with prolonged peritoneal dialysis (  0.36, P  0.001). adults with ESRD since childhood. There are concerns
Conclusion. Young adult patients with pediatric ESRD are that, as in patients with adult onset of ESRD, theseat risk for LVH caused by hypertension and for aortic valve
patients are at risk for cardiovascular death at a verycalcification. Diastolic function decreases with age and is en-
hanced by a current low GFR. Prolonged peritoneal dialysis young age. We conducted a national long-term follow-
may enhance aortic valve calcification. up study to evaluate late effects of renal insufficiency in
children (LERIC). The cohort consisted of all Dutch
adult patients that commenced RRT between 1972 and
As life expectancy has increased in children with end- 1992 at age 0 to 14 years. Recently, we reported on mor-
stage renal disease (ESRD), concern has arisen about tality and causes of death [3]. Cardiovascular disease was
found to be the cause of death in more than 40% of
Key words: cardiac function, end-stage renal disease, children, follow-up. all deceased patients. In this paper, we report on the
prevalence and extent of LVH, systolic and diastolicReceived for publication March 27, 2002
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METHODS hypertension, the burden of anemia, the use of recombi-
nant human erythropoietin (EPO), and the use and dura-Study design
tion of prescription of cyclosporine of all patients of the
The study was designed as a cohort study and consisted cohort. The observation period for all variable determi-
of a cross-sectional and a retrospective part. The aim of nants lasted from the first day of RRT until the day of
the cross-sectional study was to assess current cardiac chart review or examination at our hospital. All eventful
abnormality by ultrasound, to assess blood pressure, and periods since onset of RRT over which data could not
to assess current glomerular filtration rate (GFR) in be obtained were excluded from evaluation and recorded
transplanted patients. The aim of the retrospective part as missing patient-years. The total duration of RRT, he-
of the study was to evaluate the influence of a set of modialysis, peritoneal dialysis, and transplantation was
predefined determinants on cardiac outcome parame- expressed in years. The total duration of hypertension
ters. The study covered the total period of RRT for each was scored as follows: the mean blood pressure per 3
patient. The end of the study was marked by the day of months was calculated from all documented blood pres-
the examination for participants and the day of last chart sures and recorded on file. In hemodialysis patients, the
review for eventual nonparticipants in the cross-sectional mean of pre- and post-dialysis blood pressures was used
part of the study. The medical ethical committees of all to calculate the 3-month period mean. Over periods of
participating centers approved the study. uneventful follow-up after transplantation, in which pa-
tients were less frequently controlled than once per 3Formation of the cohort
months, the mean value of two subsequently recorded
The LERIC cohort comprises all Dutch patients who blood pressures was presumed to represent the mean
had begun chronic RRT at age 0 to 14 years between blood pressure of the intervening 3-month period. Hy-
1972 and 1992, and who were born before 1979. Patients pertension was defined as both systolic and diastolic
in whom renal function recovered within 4 months after blood pressure values above the 95th percentile for age
commencing dialysis were excluded. Pre-emptively trans- and gender, in accordance with the Task Force on Blood
planted patients were included. A list of patients, based Pressure in Children [12]. The total number of periods
on these criteria, was submitted by the National Dutch of hypertension and normal blood pressure was re-
Registry of patients on RRT [Registratie Nierfunctiever- corded. The total “burden of hypertension” was defined
vanging Nederland (RENINE), Rotterdam, The Nether- per patient as the cumulative period with hypertension,
lands]. RENINE, founded in 1985, is the Dutch source of expressed in years. The burden of anemia was expressed
the European Dialysis and Transplantation Association. as the total duration of a hemoglobin level below 5 mmol/L
The completeness of these database approaches 100% (8 g/dL).
as registration is compulsory for reimbursement of RRT.
Cross-sectional dataThe completeness of retrospective registration of pa-
tients with RRT starting before 1985 was checked by All living patients were contacted by their current
comparing RENINE data with the databases of all Dutch nephrologist and were invited to participate in the study.
centers for pediatric dialysis and kidney transplantation, Written informed consent was obtained from all partici-
as well as the databases of all centers for adult dialysis pants. Data were collected on the current body weight,
and transplantation. The procedure of cohort formation height, current use of cyclosporine, current modality of
was as follows: the list submitted by RENINE consisted RRT, and the GFR in transplanted patients. The GFR
of only registry numbers of patients, treatment modality, was based on the last measured serum creatinine, using
and the name of the last physician and hospital of treat- the Cockcroft-Gault formula [13]. A value below 25 mL/
ment. All nephrologists in The Netherlands received a min/1.73 m2 was defined as a low GFR. Blood pressure
list of those cohort patients who were under their treat- was assessed every 5 minutes during 30 minutes using
ment or had been under their treatment at the time of an Omron 705CP automated oscillatory blood presure
death. The LERIC team contacted all the physicians and device (Omron Matsusaka Co., Ltd., Tokyo, Japan). The
asked them if the list sent by RENINE was consistent Omron 705CP has been validated according to guidelines
with their registry database. Patients were contacted by of the British Hypertension Society and the United
their own physicians and invited to take part in this study. States Association for the Advancement of Medical In-
struments for clinical and research purposes [14, 15].
Data collection of determinants
Echocardiograph assessmentBetween November 1998 and August 2000, members
of the LERIC team visited 37 hospitals in The Nether- Echocardiographic studies were performed using a
lands. Data were collected on total duration of hemodial- HDI 3000 (Philips ATL, Bothell, WA, USA) or a
ysis, peritoneal dialysis and transplantation, primary re- CFM800 (GE Vingmed, Horten, Norway) equipped with
2 to 4 MHz probes allowing M-mode, two-dimensional,nal disease, age at initiation of first RRT, the burden of
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and pulsed Doppler measurements. One and the same of RRT, total duration of living with a renal graft, total
duration of hemodialysis, total duration of peritonealexperienced cardiac sonographer performed the measure-
dialysis, age at onset of RRT, blood pressure at time ofments. Echocardiography was performed according to the
investigation, total burden of hypertension, a GFR 25guidelines of American Society of Echocardiography [16].
mL/min/1.73 m2 (including dialysis status), and totalLeft ventricular end diastolic diameter (LVEDD), inter-
years of cyclosporine prescription. The relationship ofventricular wall thickness during diastole (IVST), and
all significant determinants (set at P  0.2) identifiedposterior wall thickness during diastole (PWT) were
from these univariate analyses with LVH, E/A ratio, andmeasured by M-mode. From these measurements, the left
aortic valve calcification were studied with a linear step-ventricular mass (LVM) and left ventricular mass index
wise multiple regression using the F statistic with P (LVMI) were calculated according to the Devereux for-
0.05 as criterion for selection.mula as follows: LVM  [LVEDD/10  IVST/10 
posterior wall thickness (PWT)/103  1.04]  (LVEDD/
10)313.6, and LVMILVM/(weight length/3600) RESULTS
[17]. We used reference values for the LVMI to define
The cohortLVH as in the Framingham study: in male patients, LVH
The RENINE database produced a list of 251 patients,was defined as LVMI 150 g/m2, and in female patients
who fulfilled the inclusion criteria. Checking with theas LVMI 120 g/m2 [18]. We decided to use the LVMI
local databases of all participating centers revealed thatand not the LVM as a reference for LVH, since most
one patient was mentioned twice and three patients didof our patients were severely growth retarded. The pres-
not meet the inclusion criteria. Reviewing the databasesence or absence of cardiac valve calcification was noted.
of all dialysis and transplantation centers produced twoDiastolic dysfunction was defined as an early transmitral
additional eligible patients. Thus, the cohort consistedpeak blood flow velocity divided by the atrial transmitral
of 249 patients. Of these, 62 patients (25.3%) had diedpeak blood flow (E/A ratio) 1. Systolic function was
at time of cross-sectional study. The average follow-upassessed by calculation of the shortening fraction, which
time was 15.5 years. We recorded a total of 3870 patientwas defined by the ratio of the difference between the
years of all LERIC patients, covering the whole periodend-diastolic and end-systolic dimensions to the end-
from the onset of RRT until August 2000 or the time ofdiastolic dimension (i.e., shortening fraction  (end dia-
death, with 81 patient-years (2.1%) missing. No patientsstolic diameter  end systolic diameter/end diastolic di-
were lost to follow-up. Of two patients (0.8%), who bothameter). Systolic dysfunction was defined as a shortening
died in 1974, no clinical data could be found.fraction of less than 28%.
The main characteristics of all the patients are listed
in Table 1. Of 187 patients alive, 47 (25.1%) declinedAnalysis
to participate in the cross-sectional study, leaving 140
A comparison of nominal variables on clinical parame- subjects. No significant differences were found in age,
ters of participants and nonparticipants of the cross-sec- gender, age of onset of RRT, and therapy characteristics
tional study was performed using the chi-squared test. between participants and nonparticipants of the cross-
Mean values, or prevalence of outcomes measures, were sectional study. Antihypertensive drugs were used by 70
calculated for all patients, for male and female patients out of 130 patients (53.8%), of whom 26 (20%) used an-
apart, and for the following four therapeutic subgroups giotensin-converting enzyme (ACE) inhibitors, 35 (26.9%)
of patients: (1) transplanted patients with a GFR 25 calcium channel blockers, and 45 (34.6%) beta blockers.
mL/min/1.73 m2, (2) transplanted patients with a GFR In 43 (30.7%) participants, the onset of RRT was before
25 mL/min/1.73 m2, (3) all transplanted patients, and the age of 10 years.
(4) all patients currently on dialysis. Mean values of
continuous variables in the therapeutic subgroups were Cross-sectional data
compared using the Mann-Whitney test. The prevalence Mean age of all participants was 29.2 years (range, 20.9
of aortic valve calcification in all therapeutic subgroups to 41 years). Of all 140 patients, 110 were living with a
was compared using the chi-squared test. Pearson’s cor- functioning renal graft, 19 were on hemodialysis, and 11
relation was assessed between E/A ratio and intraven- on peritoneal dialysis. Mean LVMI of all 75 male patients
tricular dimensions for all patients, transplanted patients was 150 g/m2, of all female patients 119 g/m2. Of all male
and dialysis patients, in order to analyze the relation patients, 47% had a LVMI exceeding 150 g/m2, and of all
between diastolic function and change in ventricular female patients 39% had a LVMI exceeding 120 g/m2,
anatomy. Pearson’s correlation was also assessed for all both consistent with LVH. An E/A ratio1.0 was found
patients between LVMI, E/A ratio, aortic valve calcifi- in 18 (13%) patients, and calcification of the aortic valve
cation and the following potential determinants: gender, in 27 (19%) patients. We found a normal systolic function
in all but one patient (Table 2).modality of RRT at time of investigation, total duration
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Table 1. Demographic and clinical characteristics at the time of echocardiography
Participants Non-participants
Parameters N  140 N  47
Mean age at time of investigation years (range) 29.2 (20.7–41.8) 29.9 (21.3–41.6)
Male gender number (range)a 75/140 (54%) 27/45 (60%)
Weight kg (range) 61.5 (38–122) No data
Height cm (range) 161 (139–186) No data
Treatment at time of investigation number a 111/140 (79.3%) 38/47 (80%)
Hemodialysis at time of investigation number a 18/140 (12.9%) 5/47 (11%)
Peritoneal dialysis at time of investigation number a 11/140 (7.9%) 4/47 (8.5%)
Mean duration of renal replacement therapy 18 years 83/140 (59%) 29/47 (62%)
Age at onset of renal replacement therapy years (range) 10.9 (1.9–15) 10.8 (2.7–14.9)
Mean duration of renal replacement therapy years (range) 18.3 (6–30) 18.9 (10.5–27.5)
Mean duration of hemodialysis years (range) 3.6 (0–25.7) 2.4 (0.2–10.4)
Mean duration of peritoneal dialysis years (range) 0.9 (0–12.3) 1.2 (0–14.7)
Mean duration of renal transplant years (range) 13.5 (0–28.9) 15.3 (2.8–26.9)
a Number of patients
Table 2. Blood pressure, height, weight, and echocardiographic measurements in male and female patients
Male patients Female patients
(N  75) (N  65)
Weight kg 64 (range 38 to 98) 58 (range 39 to 85)
Height cm 165 (range 140 to 186) 156 (range 39 to 174)
Body surface kg/m2 1.7 (range 1.2 to 2.1) 1.6 (range 1.3 to 2.0)
Mean systolic blood pressure mm Hg 135 (range 81 to 179) 120 (range 65 to 186)
Mean diastolic blood pressure mm Hg 83 (range 45 to 112) 79 (range 43 to 116)
Interventricular septal thickness mm 10.9 (SD 2.4) 9.7 (SD 2.9)
Posterior wall thickness mm 10.8 (SD 2.0) 9.3 (SD 1.8)b
Left ventricular end-diastolic diameter mm 50.7 (SD 6.0) 47.0 (SD 5.2)
Left ventricular mass g 257 (SD 91) 186 (SD 65)b
Left ventricular mass index g/m2 150 (SD 45) 119 (SD 43)b
Left ventricular hypertrophya number 35 (47%) 25 (39%)b
Left ventricular mass/left ventricular volume ratio g/mL 2.1 (range 1.0 to 3.4) 1.8 (range 1.0 to 4.6)
E/A ratio 1.5 (range 0.5 to 3.6) 1.6 (range 0.9 to 3.2)
E/A ratio 1.0 number 9 (12%) 9 (14%)
Aortic valve regurgitation number 17 (23%) 15 (23%)
Mitral valve regurgitation number 22 (29%) 19 (29%)
Shortening fraction % 39 (range 27 to 61) 39 (range 28 to 85)
Aortic valve calcifications number 19 (25%) 8 (12%)
Wall irregularities number 24 (32%) 14 (22%)
Abbreviations are: E, early diastolic transmitral peak blood flow; A, atrial diastolic transmitral peak blood flow.
a Left ventricular hypertrophy (LVH), defined as left ventricular mass index (LVMI) 150 in male patients and LVMI 120 in female patients
b Posterior wall thickness, left ventricular mass, and left ventricular mass index measured in 64 of 65 female patients
Relation between diastolic function and Effect of renal function on outcome measures
ventricular dimensions Mean E/A ratio of patients currently on dialysis was
1.26, and of all transplanted patients 1.59 (0.32; 95%In all patients, decrease in E/A ratio was associated
with an increase in the interventricular septal thickness CI 0.12; 0.53, P  0.002). Mean LVMI of transplanted
patients with a GFR below 25 mL/min/1.73 m2 (N  7)(IVST) (R  0.21; P  0.01), weakly with an increase
in the PWT (R  0.17; P  0.05), but not with the left was 177 g/m2, of transplanted patients with a GFR above
25 mL/min/1.73 m2 (N  103) was 135 g/m2(42; 95%ventricular end-diastolic diameter. Also, a decrease in
CI 6, 77; P  0.04). No significant difference was foundE/A ratio was correlated with an increase in LVM/left
between the mean LVMI of transplanted patients withventricular volume ratio (R0.23; P 0.007; Table 3).
a GFR above 25 mL/min/1.73 m2 and dialysis patientsA stronger (R0.35) association was found between a
(Table 4).low E/A ratio and an increase in the interventricular
septal thickness in dialysis patients, whereas in trans-
Determinants of LVH, diastolic dysfunction, andplanted patients a low E/A ratio was equally associated
aortic valve calcificationwith an increase in interventricular septal and PWT.
However, these associations were not statistically sig- Multiple regression analysis revealed the following as-
sociations between a high LVMI with a high currentnificant, probably due to the small numbers (all P 
0.06; Table 3). mean blood pressure (  0.46; P  0.001) and male
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Table 3. Univariate analysis: Correlation between E/A ratio and left ventricular dimensions in all patients, transplanted and dialysis patients
E/A: All patients EA: Transplant patients EA: Dialysis patients
R P value R P value R P value
Interventricular septal thickness 0.21 0.01 0.19 0.06 0.35 0.06
Left ventricular end-diastolic diameter
Posterior wall thickness 0.17 0.05 0.19 0.06
Left ventricular mass/left ventricular volume 0.23 0.007 0.20 0.04
Abbreviations are: E, early diastolic mitral peak blood flow; A, atrial diastolic mitral peak flow. Note: Only significant associations are shown (set at P  0.2).
Table 4. Mean values of left ventricular mass index (LVMI) and E/A ratio, and the prevalence of calcification of the aortic valve (AoVc)
in transplanted patients with a glomerular filtration rate (GFR) 25 m/min/1.73 m2, transplanted patients with a GFR25 mL/min/1.73
m2, and in all dialysis patients
Transplanted GFR 25 Transplanted GFR 25 Dialysis Transplanted GFR 25 Transplanted GFR 25
(N  103) (N  7) (N  30) Transplanted GFR 25 Dialysis
Mean LVMI g/m2 135	42 177	55 130	53 42a P  0.04 5a P  0.3
E/A ratio 1.61	0.53 1.17	0.40 1.26	43 0.44a P  0.03 0.35a P  0.002
AoVc n% 15.5% 29.7% 30.0% 3.5b P  0.08 3.2b P  0.07





gender (  0.21, P  0.001), a low E/A ratio with a dialysis and transplanted patients could imply that LVH
in our patients is merely the result of current hyperten-higher age at time of investigation (  0.28; P 
0.001), and a GFR25 mL/min/1.73 m2 ( 0.29; P sion and can be regarded as an adequate response to the
increased pressure. The physiologic character of LVH as0.001), and aortic valve calcification with a long total
period of peritoneal dialysis (  0.36; P  0.001). A observed in older dialysis patients has been described
as the result of an “inadequate” response on volumelong duration of anemia was associated with a decrease in
E/A ratio and aortic valve calcification in the univariate overload [9, 19, 20]. In these patients, the blood pressure-
related increase of the LVM/left ventricular volume ratioanalysis, but not in the multivariate analysis. No differ-
ence in LVMI or in the prevalence of aortic valve calcifi- is inadequate. In other words, the increase in ventricular
mass, which is needed to cope with the increase in ven-cation was found between transplanted patients and dial-
ysis patients, even if we excluded transplanted patients tricular volume caused by volume overload, appears to
be insufficient in these older dialysis patients. This seemswith a low GFR from the analyses. All univariate and
to contrast with our results in young adults with ESRD.multivariate associations between determinants and out-
Compared to older dialysis patients, the LVM/left ven-come for all patients, transplanted and dialysis patients,
tricular volume ratio in our patients was high, both inare shown in Tables 5 and 6.
transplanted patients and in patients currently on dial-
ysis. The pattern observed in our patients is more similar
DISCUSSION to those observed in patients with essential hypertension
In this study, we aimed to determine the extent of [21, 22]. Therefore, it seems that in these relatively young
LVH, systolic and diastolic dysfunction and aortic valve patients, the increase of the LVM appears to be mainly
calcification in young adults with ESRD since childhood. caused by the current pressure load. The fact that the
We also examined relationships between clinical charac- LVMI was not apparently associated with the burden of
teristics and outcome measures. hypertension in the past suggests that an increased LVMI
is a reversible condition in these young adult patients
Left ventricular hypertrophy and diastolic dysfunction with ESRD since childhood.
We found LVH in nearly 50% of all male and in Despite the high prevalence of LVH, only 13% of our
nearly 40% of all female patients. As expected, LVH patients had a diastolic dysfunction, defined as an E/A
was associated with hypertension at time of assessment. ratio below 1.0. Yet, and also contrary to data obtained
However, to our surprise, the burden of hypertension in in older dialysis patients [9], we found a negative associa-
the past was not directly associated with an increase in tion between the LVM/left ventricular volume ratio and
LVM, nor was the total duration of RRT or dialysis. the E/A ratio. In other words, in our patients diastolic
dysfunction was associated with a high LVM/left ventric-The fact that we found no difference in LVMI between
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Table 5. Univariate analysis: Correlation between left ventricular mass index (LVMI), E/A ratio, calcification of the aortic valve, and
potential disease and therapy-related determinants in all patients
LVMI E/A Calcification of aortic valve
R P value R P value R P value
Male gender 0.34 0.001 0.17 0.05
Duration renal replacement therapy 0.22 0.009
Duration transplantation
Duration hemodialysis 0.20 0.02 0.13 0.1
Duration peritoneal dialysis 0.14 0.1 0.29 0.001
Age onset renal replacement therapy
Age at time of investigation 0.28 0.001
Mean blood pressure 0.52 0.001
Duration hypertensiona 0.10 0.2 0.12 0.2
Glomerular filtration rate 25b 0.31 0.001 0.16 0.07
Dialysisc 0.25 0.003 0.14 0.1
Duration of anemiad 0.17 0.05 0.22 0.009
Duration of cyclosporine 0.18 0.03
GFR 25, glomerular filtration rate 25 mL/min/1.73 m2, included dialysis patients. Note: Only significant associations are shown (set at P  0.2).
a Total duration of periods with blood pressure P  0.95
b Included dialysis patients
c On dialysis at time of investigation
d Total duration of hemoglobin 5 mmol/L (8 g/dL)
Table 6. Determinants of left ventricular mass index (LVMI), E/A ratio (EA) and calcification of the aortic valve (AoV) analyzed by
multivariate regression with stepwise strategy of all patients
LVMI EA AoVc
 P value  P value  P value
Male gender 0.21 0.009
Duration PD 0.36 0.001
Age at time of investigation 0.28 0.001
Mean BP 0.46 0.001
GFR 25a 0.29 0.001
Abbreviations are: RRT, renal replacement therapy; Tx, renal transplantation; HD, hemodialysis; PD, peritoneal dialysis; BP, blood pressure; , standardized
coefficient. Note: Only significant associations are shown (set at P  0.05).
a GFR 25, glomerular filtration rate 25 mL/min/1.73 m2
ular volume ratio. This accounted for transplanted pa- tions were never associated with a hemodynamically sig-
tients as well as patients currently on dialysis. This pat- nificant obstruction, the appearance of valve calcification
tern is also more compatible with data obtained in is extremely uncommon in healthy subjects of this age.
patients with essential hypertension, than with data from As to the significance of this finding, Otto et al [24]
(older) dialysis patients [21–23]. In patients with essential have demonstrated that, even in the absence of a flow
hypertension, anatomic ventricular changes precede de- obstruction, aortic valve calcification is associated with
crease in diastolic function [23]. The fact that in our an increase in mortality risk of 50% in the nondiseased
patients a low E/A ratio was associated with increased elderly. In the last 10 years, it has been recognized that
age and with a current low GFR suggests, that in our aortic calcification occur in ESRD patients about 10 to
transplanted patients, loss of diastolic function is only a 20 years earlier than in the general population and that
late complication of LVH under nonuremic conditions. it can be regarded as an independent risk factor for
Strikingly, a decrease in E/A ratio was associated with mortality in these patients [10, 11, 24, 25]. For example,
only an increase of the interventricular septal thickness Mazzaferro et al [26] found 22% to 25% mitral valvein dialysis patients, whereas in transplanted patients it
calcification in hemodialysis patients aged between 20was associated with an increase of both interventricular
and 40 years. Coronary ischemia and cardiac conductionthickness and PWT. This is compatible with data from
defects are the most probable links between aortic valveother studies and it reflects the difference between the
calcification and mortality. Aortic valve calcification inconcentric character of hypertrophy caused by hyperten-
ESRD patients could reflect a more generalized arterysion and the more asymmetric hypertrophy seen in dial-
disease with calcification of the coronary arteries. Braunysis patients [19].
et al [27], indeed, showed, using computed tomography
Aortic valve calcification (CT), that aortic valve calcification in ESRD patients is
associated with calcification of the myocardium andAortic valve calcification was seen in 25% of all male
and 12% of all female patients. Although these calcifica- large- or medium-sized arteries, including coronary ar-
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teries. Such myocardial calcification could impair the calcification could enhance the risk of acute myocardial
infarction at a very young age in these patients.conduction system, causing lethal arrhythmia or conduc-
tion disturbances. Shurmur et al [28] has, in fact, shown
Limitations of the studythe association between cardiac conduction defects and
Echocardiography was performed in only 140 out ofaortic valve calcification in dialysis patients.
187 patients, and our cohort comprised only a few pa-We found a strong association between total duration
tients who had started RRT under the age of 6 years.of peritoneal dialysis and the appearance of aortic valve
Nevertheless, since no significant differences in the distri-calcification. Aging, a high serum calcium-phosphate prod-
bution of disease parameters and therapy mode existeduct and mechanical stress caused by chronic overhydra-
between participants and nonparticipants of the study,tion have generally been accepted as the most important
we believe that this group is representative for the wholeethiologic factors [10, 11, 24, 26]. However, and in accor-
group, and that no obvious selection of a special high-dance with our results, Fernandez-Reyes et al [25] found
risk group seems to have occurred. As a result of anthe duration of peritoneal dialysis to be an independent
incomplete registration, we could not obtain reliable datarisk factor for mitral and aortic valve calcification in
on calcium-containing phosphate binders, vitamin D sub-continuous ambulatory peritoneal dialysis (CAPD) pa-
stitution, and on serum calcium, phosphate, and choles-tients. An explanation for this phenomenon might be
terol, retrospectively. A prospective study evaluatingbecause chronic overhydration is a more common situa-
these potential determinants for aortic valve calcificationtion in patients on peritoneal dialysis than in hemodialy-
is warranted.sis patients. Issad et al [29] have reported a frequently
occurring and underestimated overhydration in CAPD
patients who underwent renal transplantation. In a large CONCLUSION
multicenter study to the adequacy of dialysis, Merkus
LVH is highly prevalent in young adults transplanted,et al [30] found that in hemodialysis patients, the cardio-
as well as dialysis patients with ESRD since childhood.vascular co-morbidity at onset of RRT appeared to be
It is directly related to the extent of current hypertension,the strongest predictor of death. On the contrary, in
but leads to diastolic dysfunction only in a minority of
peritoneal dialysis patients systolic blood pressure was
patients. Diastolic function decreases over time and this
the most important determinant of death. Another ex-
is enhanced by a low GFR. The appearance of aortic
planation of the relation between peritoneal dialysis du-
valve calcification is associated with a long duration of
ration and cardiac valve calcification might be the fact
peritoneal dialysis. A stricter reduction of volume over-
that an uncontrolled serum calcium-phosphate balance load in children on peritoneal dialysis, prevention of
has been more apparent in peritoneal dialysis patients a high serum calcium phosphate, and a more vigorous
than in hemodialysis patients, especially in the period treatment of hypertension seem to be important targets
when only high calcium dialysate was available. Indeed, in order to reduce the incidence of these potentially
there are studies from the early 1990s that have reported lethal cardiac abnormalities.
a higher incidence of hypercalcemia in peritoneal dialysis
patients compared to hemodialysis patients [31, 32]. ACKNOWLEDGMENTS
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